Fundraising Fox
/Companies
Sign in

Novira Therapeutics

Acquired

Doylestown, US · 4 known investors

Find your way into Novira Therapeutics

Acquired by Johnson & Johnson (Janssen) November 2015 · terms undisclosed — undisclosed · source ↗

Novira Therapeutics was a Doylestown, PA-based clinical-stage biopharmaceutical company developing small-molecule antiviral drugs, including capsid inhibitors, to cure chronic hepatitis B infection.

Biotech

Founders & leadership

OF
Osvaldo FloresFounder
DE
Daniel E. GeffkenExecutive
GH
George HartmanExecutive
GK
Gregory KorbelDirector of Business Development & Operations2012–2015

Board

TSTim Shannon
Tim ShannonBoard directorGeneral Partner at Canaan Partners
SRScott Rocklage
Scott RocklageBoard directorManaging Partner at 5AM Ventures with over 20 years of healthcare management experience
AF
Anthony Ford-HutchinsonBoard director
GG
Gianni GromoBoard director

Investors · 4

Canaan Partnerslisted by Canaan PartnersStamford · $500K – $20M

How we know: Canaan Partners's portfolio page · funding news · Not right? Tell us

5AM VenturesreportedSan Francisco · $100K – $4M

How we know: a partner's Signal profile · funding news · Not right? Tell us

Versant VenturesreportedSan Francisco · $250K – $5M

How we know: funding news · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$37M disclosed across 2 rounds · 2012–2014

▶$9MraisedDec 2014 · 10 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Scott M. RocklageDirector
  • Tim ShannonDirector
  • Christian S. SchadeExecutive Officer, Director
  • Nathaniel BrownExecutive Officer
  • Anthony Ford-HutchinsonDirector
  • Gianni GromoDirector
  • Osvaldo FloresExecutive Officer
  • George HartmanExecutive Officer
  • Klaus KlumppExecutive Officer
  • Douglas CarrExecutive Officer
Offering amount
$9M
Amount sold
$9M
Proceeds to insiders
$1.3M
First sale
Dec 2014
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$28MraisedFeb 2014 · 10 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Anthony Ford-HutchinsonDirector
  • Daniel E. GeffkenExecutive Officer
  • Tim ShannonDirector
  • Osvaldo FloresExecutive Officer, Director
  • George HartmanExecutive Officer
  • Gregory KorbelExecutive Officer
  • Scott RocklageDirector
  • Gianni GromoDirector
Offering amount
$29.8M
Amount sold
$28M
Minimum investment
$58.2K
Proceeds to insiders
$700K
First sale
Aug 2012
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Founder mafia

3 people who came through Novira Therapeutics went on to found or lead other companies.

Kush M ParmarBoard Observer and Acting VP, Strategy and Corporate DevelopmentFounded Homology MedicinesTim ShannonDirectorFounded Quarry TheraROGER POMERANTZChairman of the Scientific Advisory Board and Senior Advisor to the Board of DirectorsFounded Seres Therapeutics

Frequently asked questions

What does Novira Therapeutics do?
Novira Therapeutics was a Doylestown, PA-based clinical-stage biopharmaceutical company developing small-molecule antiviral drugs, including capsid inhibitors, to cure chronic hepatitis B infection.
Who founded Novira Therapeutics?
Novira Therapeutics was founded by Osvaldo Flores.
Who are Novira Therapeutics's investors?
Novira Therapeutics's investors include BioAdvance, Canaan Partners, 5AM Ventures, Versant Ventures.
How much funding has Novira Therapeutics raised?
Novira Therapeutics has disclosed $37M raised across 2 rounds.
Where is Novira Therapeutics headquartered?
Novira Therapeutics is headquartered in Doylestown, US.